Essex Welcome you!
Essex Bio-Technology Limited (“EssexBio Group” and the “Company”) was incorporated in the Cayman Islands on 31st July, 2000 and has been listed on the Stock Exchange of Hong Kong since 27th June, 2001. Essex specializes in biopharmaceutical drug development based on recombinant DNA technology. It is principally engaged in the manufacture and sale of biopharmaceutical products for the treatment and healing of surface wounds and eye wounds. The Group also engaged in the research and development of bFGF products for new indications, as well as other ophthalmic pharmaceutical projects. A series of genetically engineered bio-pharmaceutical drugs have been successfully developed and three of them were classified as State-level Category I new drugs. The main brands of the Company's products are Beifuji, Beifushu and Beifuxin
Tell Me More

Results of the core

Committed to scientific and technological development and innovation.

Antibody

Nano antibody
Bi-specific antibody

Growth factor

New formulation of rh-bFGF
PDGF application

Single dose Platform

9 drugs under developer

Leadership style

Our Leaders is the best way to show our work.

img02
img02
img02
img02
img02
img02

Contact Us

If you have some Questions or need Help! Please Contact Us!

Our Business Office

No.88, sci-tech road 6, high-tech zone, zhuhai

yuguoquan@essex.com.cn

Business Hours

Weekdays:9am to 8pm

Saturday:9am to 2pm

Sunday:Closed